The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Adamantane-2-spiro-3'-9'-carboxy-1',2',4',5'-tetraoxaspiro[5.5]undecane ID: ALA1830034
PubChem CID: 56660000
Max Phase: Preclinical
Molecular Formula: C17H24O6
Molecular Weight: 324.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)C1CCC2(CC1)OOC1(OO2)C2CC3CC(C2)CC1C3
Standard InChI: InChI=1S/C17H24O6/c18-15(19)12-1-3-16(4-2-12)20-22-17(23-21-16)13-6-10-5-11(8-13)9-14(17)7-10/h10-14H,1-9H2,(H,18,19)
Standard InChI Key: QLBXWPYRCIWKCQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 27 0 0 0 0 0 0 0 0999 V2000
-4.6824 -7.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7804 -6.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8700 -7.2325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2929 -7.3352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3667 -7.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5496 -7.5513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4423 -6.4905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6268 -6.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3810 -6.0548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1314 -6.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4688 -6.8394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8873 -6.1195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7155 -6.1220 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7129 -7.5627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8784 -7.5619 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0586 -7.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7618 -7.5578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1783 -6.8463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7680 -6.1306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0586 -6.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0070 -6.8502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4181 -7.5698 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4246 -6.1343 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
1 2 1 0
1 3 1 0
2 4 1 0
3 5 1 0
11 15 1 0
12 13 1 0
13 10 1 0
10 14 1 0
14 15 1 0
11 16 1 0
4 6 1 0
5 6 1 0
7 8 1 0
3 7 1 0
2 9 1 0
11 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
6 10 1 0
18 21 1 0
10 8 1 0
21 22 1 0
8 9 1 0
21 23 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.37Molecular Weight (Monoisotopic): 324.1573AlogP: 3.02#Rotatable Bonds: 1Polar Surface Area: 74.22Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.68CX Basic pKa: ┄CX LogP: 3.79CX LogD: 0.47Aromatic Rings: ┄Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: 0.93
References 1. Wang X, Zhao Q, Vargas M, Dong Y, Sriraghavan K, Keiser J, Vennerstrom JL.. (2011) The activity of dispiro peroxides against Fasciola hepatica., 21 (18): [PMID:21802291 ] [10.1016/j.bmcl.2011.07.024 ] 2. Yang J, Tu Z, Xu X, Luo J, Yan X, Ran C, Mao X, Ding K, Qiao C.. (2017) Novel conjugates of endoperoxide and 4-anilinoquinazoline as potential anticancer agents., 27 (6): [PMID:28236592 ] [10.1016/j.bmcl.2017.02.023 ]